Medpace Holdings, Inc. Deferred Income Tax Expense (Benefit)
Medpace Holdings, Inc. (MEDP) reported Deferred Income Tax Expense (Benefit) of $22.82 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-07-23
- Medpace Holdings, Inc. deferred income tax expense (benefit) for the quarter ending 2026-06-30 was $4.28M, a 87.45% decline year-over-year.
- Medpace Holdings, Inc. deferred income tax expense (benefit) for the quarter ending 2026-03-31 was $18.54M, a 2375.70% increase year-over-year.
- Medpace Holdings, Inc. deferred income tax expense (benefit) for the quarter ending 2025-12-31 was $17.55M.
- Medpace Holdings, Inc. deferred income tax expense (benefit) for the quarter ending 2025-09-30 was $28.51M.
- Medpace Holdings, Inc. deferred income tax expense (benefit) for fiscal 2025 was $80.92M.
- Medpace Holdings, Inc. deferred income tax expense (benefit) for fiscal 2024 was -$26.62M.
- Medpace Holdings, Inc. deferred income tax expense (benefit) for fiscal 2023 was -$24.98M.
- Medpace Holdings, Inc. deferred income tax expense (benefit) for fiscal 2022 was -$23.01M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $4.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $22.82M 10-Q · filed 2026-07-23 | $40.38M derived: sum of 3 quarters · filed 2026-07-23 | $68.89M derived: sum of 4 quarters · filed 2026-07-23 | |
| 2026-03-31 | $18.54M 10-Q · filed 2026-04-23 | $36.09M derived: sum of 2 quarters · filed 2026-04-23 | $64.60M derived: sum of 3 quarters · filed 2026-04-23 | $98.71M derived: sum of 4 quarters · filed 2026-07-23 | |
| 2025-12-31 | $17.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $46.06M derived: sum of 2 quarters · filed 2026-02-10 | $80.17M derived: sum of 3 quarters · filed 2026-07-23 | $80.92M 10-K · filed 2026-02-10 | |
| 2025-09-30 | $28.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $62.62M derived: sum of 2 quarters · filed 2026-07-23 | $63.37M 10-Q · filed 2025-10-23 | $39.18M derived: sum of 4 quarters · filed 2026-07-23 | |
| 2025-06-30 | $34.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $34.86M 10-Q · filed 2026-07-23 | $10.67M derived: sum of 3 quarters · filed 2026-07-23 | $9.15M derived: sum of 4 quarters · filed 2026-07-23 | |
| 2025-03-31 | $749.00K 10-Q · filed 2026-04-23 | -$23.44M derived: sum of 2 quarters · filed 2026-04-23 | -$24.95M derived: sum of 3 quarters · filed 2026-04-23 | -$25.01M derived: sum of 4 quarters · filed 2026-04-23 | |
| 2024-12-31 | -$24.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$25.70M derived: sum of 2 quarters · filed 2026-02-10 | -$25.76M derived: sum of 3 quarters · filed 2026-02-10 | -$26.62M 10-K · filed 2026-02-10 | -$26.63M 10-K · filed 2025-02-11 |
| 2024-09-30 | -$1.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | -$1.57M derived: sum of 2 quarters · filed 2025-10-23 | -$2.43M 10-Q · filed 2025-10-23 | -$16.10M derived: sum of 4 quarters · filed 2026-02-10 | |
| 2024-06-30 | -$54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | -$919.00K 10-Q · filed 2025-07-22 | -$14.59M derived: sum of 3 quarters · filed 2026-02-10 | -$22.19M derived: sum of 4 quarters · filed 2026-02-10 | |
| 2024-03-31 | -$865.00K 10-Q · filed 2025-04-22 | -$14.54M derived: sum of 2 quarters · filed 2026-02-10 | -$22.14M derived: sum of 3 quarters · filed 2026-02-10 | -$24.78M derived: sum of 4 quarters · filed 2026-02-10 | |
| 2023-12-31 | -$13.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$21.27M derived: sum of 2 quarters · filed 2026-02-10 | -$23.92M derived: sum of 3 quarters · filed 2026-02-10 | -$24.98M 10-K · filed 2026-02-10 | -$25.12M 10-K · filed 2024-02-13 |
| 2023-09-30 | -$7.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-22 | -$10.24M derived: sum of 2 quarters · filed 2024-10-22 | -$11.31M 10-Q · filed 2024-10-22 | -$32.20M derived: sum of 4 quarters · filed 2025-02-11 | |
| 2023-06-30 | -$2.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-23 | -$3.71M 10-Q · filed 2024-07-23 | -$24.60M derived: sum of 3 quarters · filed 2025-02-11 | -$25.28M derived: sum of 4 quarters · filed 2025-02-11 | |
| 2023-03-31 | -$1.06M 10-Q · filed 2024-04-23 | -$21.95M derived: sum of 2 quarters · filed 2025-02-11 | -$22.64M derived: sum of 3 quarters · filed 2025-02-11 | -$23.36M derived: sum of 4 quarters · filed 2025-02-11 | |
| 2022-12-31 | -$20.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | -$21.57M derived: sum of 2 quarters · filed 2025-02-11 | -$22.30M derived: sum of 3 quarters · filed 2025-02-11 | -$23.01M 10-K · filed 2025-02-11 | |
| 2022-09-30 | -$687.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-24 | -$1.41M derived: sum of 2 quarters · filed 2023-10-24 | -$2.13M 10-Q · filed 2023-10-24 | -$42.54M derived: sum of 4 quarters · filed 2024-02-13 | |
| 2022-06-30 | -$726.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | -$1.44M 10-Q · filed 2023-07-25 | -$41.85M derived: sum of 3 quarters · filed 2024-02-13 | -$41.22M derived: sum of 4 quarters · filed 2024-02-13 | |
| 2022-03-31 | -$713.00K 10-Q · filed 2023-04-25 | -$41.12M derived: sum of 2 quarters · filed 2024-02-13 | -$40.49M derived: sum of 3 quarters · filed 2024-02-13 | -$39.11M derived: sum of 4 quarters · filed 2024-02-13 | |
| 2021-12-31 | -$40.41M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | -$39.78M derived: sum of 2 quarters · filed 2024-02-13 | -$38.40M derived: sum of 3 quarters · filed 2024-02-13 | -$37.11M 10-K · filed 2024-02-13 | |
| 2021-09-30 | $632.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | $2.01M derived: sum of 2 quarters · filed 2022-10-25 | $3.30M 10-Q · filed 2022-10-25 | -$3.08M derived: sum of 4 quarters · filed 2023-02-14 | |
| 2021-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-26 | $2.67M 10-Q · filed 2022-07-26 | -$3.72M derived: sum of 3 quarters · filed 2023-02-14 | $778.00K derived: sum of 4 quarters · filed 2023-02-14 | |
| 2021-03-31 | $1.29M 10-Q · filed 2022-04-26 | -$5.09M derived: sum of 2 quarters · filed 2023-02-14 | -$600.00K derived: sum of 3 quarters · filed 2023-02-14 | $737.00K derived: sum of 4 quarters · filed 2023-02-14 | |
| 2020-12-31 | -$6.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | -$1.89M derived: sum of 2 quarters · filed 2023-02-14 | -$552.00K derived: sum of 3 quarters · filed 2023-02-14 | $527.00K 10-K · filed 2023-02-14 | |
| 2020-09-30 | $4.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-26 | $5.83M derived: sum of 2 quarters · filed 2021-10-26 | $6.91M 10-Q · filed 2021-10-26 | $14.12M derived: sum of 4 quarters · filed 2022-02-15 | |
| 2020-06-30 | $1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | $2.42M 10-Q · filed 2021-07-27 | $9.63M derived: sum of 3 quarters · filed 2022-02-15 | $10.63M derived: sum of 4 quarters · filed 2022-02-15 | |
| 2020-03-31 | $1.08M 10-Q · filed 2021-04-27 | $8.29M derived: sum of 2 quarters · filed 2022-02-15 | $9.29M derived: sum of 3 quarters · filed 2022-02-15 | $10.47M derived: sum of 4 quarters · filed 2022-02-15 | |
| 2019-12-31 | $7.21M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $8.21M derived: sum of 2 quarters · filed 2022-02-15 | $9.39M derived: sum of 3 quarters · filed 2022-02-15 | $10.05M 10-K · filed 2022-02-15 | |
| 2019-09-30 | $999.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $2.18M derived: sum of 2 quarters · filed 2020-10-27 | $2.84M 10-Q · filed 2020-10-27 | -$479.00K derived: sum of 4 quarters · filed 2021-02-16 | |
| 2019-06-30 | $1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | $1.84M 10-Q · filed 2020-07-28 | -$1.48M derived: sum of 3 quarters · filed 2021-02-16 | $6.07M derived: sum of 4 quarters · filed 2021-02-16 | |
| 2019-03-31 | $656.00K 10-Q · filed 2020-04-29 | -$2.66M derived: sum of 2 quarters · filed 2021-02-16 | $4.88M derived: sum of 3 quarters · filed 2021-02-16 | $4.85M derived: sum of 4 quarters · filed 2021-02-16 | |
| 2018-12-31 | -$3.32M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $4.23M derived: sum of 2 quarters · filed 2021-02-16 | $4.19M derived: sum of 3 quarters · filed 2021-02-16 | $3.94M 10-K · filed 2021-02-16 | |
| 2018-09-30 | $7.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $7.51M derived: sum of 2 quarters · filed 2019-10-29 | $7.26M 10-Q · filed 2019-10-29 | $10.92M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-06-30 | -$38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | -$286.00K 10-Q · filed 2019-07-30 | $3.37M derived: sum of 3 quarters · filed 2020-02-25 | $3.81M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-03-31 | -$248.00K 10-Q · filed 2019-04-30 | $3.41M derived: sum of 2 quarters · filed 2020-02-25 | $3.85M derived: sum of 3 quarters · filed 2020-02-25 | $3.40M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2017-12-31 | $3.66M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $4.10M derived: sum of 2 quarters · filed 2020-02-25 | $3.65M derived: sum of 3 quarters · filed 2020-02-25 | $3.24M 10-K · filed 2020-02-25 | |
| 2017-09-30 | $444.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | -$10.00K derived: sum of 2 quarters · filed 2018-10-30 | -$420.00K 10-Q · filed 2018-10-30 | -$8.86M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-06-30 | -$454.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | -$864.00K 10-Q · filed 2018-07-31 | -$9.30M derived: sum of 3 quarters · filed 2019-02-26 | -$9.39M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-03-31 | -$410.00K 10-Q · filed 2018-05-01 | -$8.85M derived: sum of 2 quarters · filed 2019-02-26 | -$8.93M derived: sum of 3 quarters · filed 2019-02-26 | -$9.11M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2016-12-31 | -$8.44M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$8.52M derived: sum of 2 quarters · filed 2019-02-26 | -$8.70M derived: sum of 3 quarters · filed 2019-02-26 | -$9.01M 10-K · filed 2019-02-26 | |
| 2016-09-30 | -$85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | -$258.00K derived: sum of 2 quarters · filed 2017-10-31 | -$568.00K 10-Q · filed 2017-10-31 | -$4.94M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-06-30 | -$173.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | -$483.00K 10-Q · filed 2017-08-01 | -$4.86M derived: sum of 3 quarters · filed 2018-02-27 | ||
| 2016-03-31 | -$310.00K 10-Q · filed 2017-05-02 | -$4.69M derived: sum of 2 quarters · filed 2018-02-27 | |||
| 2015-12-31 | -$4.38M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$12.69M 10-K · filed 2018-02-27 | |||
| 2015-09-30 | -$8.31M 10-Q · filed 2016-11-03 | ||||
| 2014-12-31 | -$9.56M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |